Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02039557

Enrollment

Registered

2014-01-17

Start date

2014-05-01

Completion date

2023-06-29

Last updated

2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Transplanted With NiCord/CordIn (Omidubicel)

Brief summary

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Interventions

GENETICNiCord®/CordIn™ (omidubicel)

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation	5 years

Countries

Netherlands, Singapore, Spain, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026